Gencurix Inc
Gencurix Inc. provides diagnostic solutions in South Korea. Its products include GenesWell BCT, a multigene diagnostic test for breast cancer; Droplex, a genetic test based on digital PCR platform; eDX, an early diagnosis for cancer with liquid biopsy; GenePro SARS-CoV-2 Test kit; GenoCTC, a circulating tumor cell isolator; and GenePro LAMP Cycler, a portable device for infectious disease detecti… Read more
Gencurix Inc (229000) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.140x
Based on the latest financial reports, Gencurix Inc (229000) has a cash flow conversion efficiency ratio of -0.140x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.28 Billion) by net assets (₩9.20 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Gencurix Inc - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Gencurix Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Gencurix Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Gencurix Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
EENERGY GROUP LS 0003
F:A1Z1
|
N/A |
|
Blueone Card Inc
PINK:BCRD
|
0.000x |
|
Wealth Invest I&T Obligationer KL
CO:WEIITOBL
|
N/A |
|
Odyssey Gold Ltd
AU:ODY
|
0.000x |
|
Oriental Interest Bhd
KLSE:5827
|
0.045x |
|
Carclo plc
PINK:CCEGF
|
-0.047x |
|
Hyungji Elite
KO:093240
|
-0.039x |
|
T7 Global Bhd
KLSE:7228
|
0.023x |
Annual Cash Flow Conversion Efficiency for Gencurix Inc (2016–2024)
The table below shows the annual cash flow conversion efficiency of Gencurix Inc from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩14.90 Billion | ₩-7.17 Billion | -0.481x | +46.80% |
| 2023-12-31 | ₩12.00 Billion | ₩-10.86 Billion | -0.905x | +43.94% |
| 2022-12-31 | ₩6.48 Billion | ₩-10.45 Billion | -1.614x | -497.94% |
| 2021-12-31 | ₩30.99 Billion | ₩-8.37 Billion | -0.270x | -6.05% |
| 2020-12-31 | ₩53.38 Billion | ₩-13.59 Billion | -0.255x | +99.24% |
| 2019-12-31 | ₩155.18 Million | ₩-5.22 Billion | -33.651x | -6050.17% |
| 2018-12-31 | ₩9.20 Billion | ₩-5.03 Billion | -0.547x | +35.20% |
| 2017-12-31 | ₩6.41 Billion | ₩-5.41 Billion | -0.844x | -15.80% |
| 2016-12-31 | ₩8.20 Billion | ₩-5.98 Billion | -0.729x | -- |